RU2016110925A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016110925A3 RU2016110925A3 RU2016110925A RU2016110925A RU2016110925A3 RU 2016110925 A3 RU2016110925 A3 RU 2016110925A3 RU 2016110925 A RU2016110925 A RU 2016110925A RU 2016110925 A RU2016110925 A RU 2016110925A RU 2016110925 A3 RU2016110925 A3 RU 2016110925A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361960740P | 2013-09-26 | 2013-09-26 | |
| US61/960,740 | 2013-09-26 | ||
| PCT/IB2014/002746 WO2015044788A1 (en) | 2013-09-26 | 2014-09-26 | Prostaglandin f2alpha and analogues thereof for treating atrophic cutaneous scarring |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016110925A RU2016110925A (ru) | 2017-11-01 |
| RU2016110925A3 true RU2016110925A3 (enExample) | 2018-07-13 |
| RU2690183C2 RU2690183C2 (ru) | 2019-05-31 |
Family
ID=52282772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016110925A RU2690183C2 (ru) | 2013-09-26 | 2014-09-26 | Простагландин f2 альфа и его аналоги для лечения атрофического кожного рубцевания |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10039770B2 (enExample) |
| EP (1) | EP3049088B1 (enExample) |
| JP (1) | JP6453318B2 (enExample) |
| KR (1) | KR102221499B1 (enExample) |
| CN (1) | CN105658221B (enExample) |
| AU (1) | AU2014326298B2 (enExample) |
| BR (1) | BR112016006426A2 (enExample) |
| CA (1) | CA2924460A1 (enExample) |
| MX (1) | MX374476B (enExample) |
| RU (1) | RU2690183C2 (enExample) |
| WO (1) | WO2015044788A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3319607A4 (en) * | 2015-07-09 | 2019-04-03 | Galderma S.A. | METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY |
| CN106929477B (zh) * | 2017-03-20 | 2020-01-10 | 江南大学 | 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用 |
| KR20240004954A (ko) * | 2021-05-07 | 2024-01-11 | 바치바이오메드 인크. | 소분자 화합물을 사용하여 여드름-후 위축성 흉터의 외관을 개선하는 방법 (methods of using a small molecule chemical compound to reduce the appearance of post-acne atrophic scarring) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3278447A (en) | 1963-12-02 | 1966-10-11 | Cloro Bac Products Inc | Process for stabilizing chlorine dioxide solution |
| CA2003198C (en) | 1988-11-29 | 1995-03-21 | Anthony J. Dziabo, Jr. | Aqueous ophthalmic solutions and method for preserving same |
| US5736165A (en) | 1993-05-25 | 1998-04-07 | Allergan | In-the-eye use of chlorine dioxide-containing compositions |
| US6194415B1 (en) | 1995-06-28 | 2001-02-27 | Allergan Sales, Inc. | Method of using (2-imidazolin-2-ylamino) quinoxoalines in treating neural injury |
| RU2195889C2 (ru) * | 1999-05-24 | 2003-01-10 | Парамонов Борис Алексеевич | Способ дермабразии |
| US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
| US6387383B1 (en) | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
| US7405274B2 (en) * | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
| AU2009246333B2 (en) * | 2008-05-16 | 2013-05-09 | Corthera, Inc. | Method of promoting wound healing |
| EP2389939A1 (en) * | 2010-05-28 | 2011-11-30 | Novagali Pharma S.A. | Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions |
| CN102031260A (zh) * | 2010-08-24 | 2011-04-27 | 苏州圣诺生物医药技术有限公司 | 促进皮肤伤口无疤痕愈合的siRNA及应用 |
| JP2014500275A (ja) * | 2010-12-06 | 2014-01-09 | フォリカ，インコーポレイテッド | 禿頭症を治療するため、および毛髪の成長を促進するための方法 |
| BR112013019519A2 (pt) * | 2011-01-31 | 2016-08-09 | Allergan Inc | método de realce de crescimento capilar |
| US20120251613A1 (en) * | 2011-03-29 | 2012-10-04 | Agila Specialities Pvt. Ltd. | Method for treating vitiligo with a prostaglandin analogue |
| WO2014179263A1 (en) * | 2013-04-30 | 2014-11-06 | Allergan, Inc. | Therapeutic agents |
-
2014
- 2014-09-26 KR KR1020167010897A patent/KR102221499B1/ko not_active Expired - Fee Related
- 2014-09-26 RU RU2016110925A patent/RU2690183C2/ru active
- 2014-09-26 BR BR112016006426A patent/BR112016006426A2/pt active Search and Examination
- 2014-09-26 AU AU2014326298A patent/AU2014326298B2/en not_active Ceased
- 2014-09-26 US US15/021,789 patent/US10039770B2/en active Active
- 2014-09-26 JP JP2016517505A patent/JP6453318B2/ja not_active Expired - Fee Related
- 2014-09-26 MX MX2016003650A patent/MX374476B/es active IP Right Grant
- 2014-09-26 CA CA2924460A patent/CA2924460A1/en not_active Abandoned
- 2014-09-26 WO PCT/IB2014/002746 patent/WO2015044788A1/en not_active Ceased
- 2014-09-26 EP EP14824091.4A patent/EP3049088B1/en not_active Not-in-force
- 2014-09-26 CN CN201480053306.1A patent/CN105658221B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US10039770B2 (en) | 2018-08-07 |
| AU2014326298A1 (en) | 2016-04-07 |
| RU2690183C2 (ru) | 2019-05-31 |
| EP3049088B1 (en) | 2021-02-17 |
| BR112016006426A2 (pt) | 2017-08-01 |
| CA2924460A1 (en) | 2015-04-02 |
| EP3049088A1 (en) | 2016-08-03 |
| KR20160055941A (ko) | 2016-05-18 |
| AU2014326298B2 (en) | 2019-07-04 |
| JP6453318B2 (ja) | 2019-01-16 |
| US20160228453A1 (en) | 2016-08-11 |
| JP2016531872A (ja) | 2016-10-13 |
| MX374476B (es) | 2025-03-06 |
| MX2016003650A (es) | 2016-06-24 |
| CN105658221B (zh) | 2022-05-10 |
| RU2016110925A (ru) | 2017-11-01 |
| KR102221499B1 (ko) | 2021-03-02 |
| WO2015044788A1 (en) | 2015-04-02 |
| CN105658221A (zh) | 2016-06-08 |